Polyrizon Ltd (PLRZ) - Net earnings per share (EPS TTM)

Symbol and logo of brand Polyrizon (PLRZ)

The 12-month net income per share trend is based on production outsourcing to cGMP centers to ensure supply stability, while the value of -2.76 serves as the current metric. Robotic sterile polymer filling lines support efficiency, and the environmental profile relies on biomaterial handling regulations. This chart illustrates the actual ability of Polyrizon Ltd (PLRZ) to generate equity earnings for shareholders.

PLRZ (polyrizon-biotech.com) Earnings per share for the last 12 months history from 10/30/2024 to 11/10/2026

Comprehensive metric breakdowns and analytics for Polyrizon Limited (PLRZ)

- share price and expert price forecast:
General company analysis:polyrizon-biotech.com (PLRZ)
Mass-produced product of Polyrizon Limited

Long-term capital requires volatility minimization through the analysis of sustainable yield trends. For Polyrizon Ltd (PLRZ), with its capex-free patent licensing model, the dynamics of net inflows are critically important. This TTM earnings per share (EPS) metric aggregates the final annual financial result, distributing it across the total volume of shares outstanding. Growth in TTM earnings per share confirms the efficiency of scaling royalties against fixed costs. This creates the profile of a high-margin asset with low operational risk.

Competitors of Polyrizon Ltd (PLRZ)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp (UTHR)|BMRN (BioMarin Pharma) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio Corp)|Net earnings per share for the last 12 months BGM (BGM Group Ltd)|COGT (cogentbio.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|KROS (Keros Therapeutics Inc) - Earnings per one share for the last 12 months|Arcturus Pharma - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ETON (Eton Corp)|KMDA: Net earnings per share (EPS TTM)|fulcrumtx.com (FULC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Abeona Therapeutics, Inc.|MREO: Earnings per share for the trailing year|Earnings per share for the last twelve months Protalix (PLX)|Net earnings per share for the last 12 months pliantrx.com PLRX|Net earnings per share (EPS TTM) APLT (Applied Therapeutics, Inc.)|Net earnings per share (EPS TTM) aileronrx.com RNTX|GELS - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AYTU|chemomab.com (CMMB) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months SRx Health Solutions (SRXH)|Earnings per share for the last twelve months Aeterna Zentaris Inc|Earnings per share for the last twelve months CYTH|Net earnings per share for the last 12 months INZY (Inozyme Pharma, Inc.)|RPHM - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Aeterna Zentaris CSCI